Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The association of weight change in young adulthood and smoking status with risk of prostate cancer recurrence.

Khan S, Hicks V, Colditz GA, Kibel AS, Drake BF.

Int J Cancer. 2018 May 15;142(10):2011-2018. doi: 10.1002/ijc.31229. Epub 2018 Jan 10.

PMID:
29270988
2.

Pretreatment BMI Is Associated with Aggressive Clinicopathological Features of Papillary Thyroid Carcinoma: A Multicenter Study.

Yu ST, Chen W, Cai Q, Liang F, Xu D, Han P, Yu J, Huang X.

Int J Endocrinol. 2017;2017:5841942. doi: 10.1155/2017/5841942. Epub 2017 Sep 20.

3.

BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people.

Zhao R, Cheng G, Wang B, Qin C, Liu Y, Pan Y, Wang J, Hua L, Zhu W, Wang Z.

Oncotarget. 2017 Aug 2;8(39):66051-66060. doi: 10.18632/oncotarget.19790. eCollection 2017 Sep 12.

4.

Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease.

Dahran N, Szewczyk-Bieda M, Wei C, Vinnicombe S, Nabi G.

Sci Rep. 2017 Jul 5;7(1):4630. doi: 10.1038/s41598-017-04951-8.

5.

Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.

Freedland SJ, Vidal AC, Howard LE, Terris MK, Cooperberg MR, Amling CL, Kane CJ, Aronson WJ; Shared Equal Access Regional Cancer Hospital (SEARCH) Database Study Group.

Cancer. 2017 Nov 1;123(21):4199-4206. doi: 10.1002/cncr.30834. Epub 2017 Jun 27.

PMID:
28654204
6.

Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levels.

Goto K, Nagamatsu H, Teishima J, Kohada Y, Fujii S, Kurimura Y, Mita K, Shigeta M, Maruyama S, Inoue Y, Nakahara M, Matsubara A.

Mol Clin Oncol. 2017 May;6(5):748-752. doi: 10.3892/mco.2017.1223. Epub 2017 Apr 10.

7.

The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.

Khan S, Cai J, Nielsen ME, Troester MA, Mohler JL, Fontham ETH, Hendrix LH, Farnan L, Olshan AF, Bensen JT.

Prostate. 2017 Jun;77(8):878-887. doi: 10.1002/pros.23342. Epub 2017 Mar 6.

PMID:
28261834
8.

Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma.

Yan L, Nielsen FH, Sundaram S, Cao J.

Oncotarget. 2017 Apr 4;8(14):23303-23311. doi: 10.18632/oncotarget.15055.

9.

The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.

Khan S, Cai J, Nielsen ME, Troester MA, Mohler JL, Fontham ET, Hendrix LH, Farnan L, Olshan AF, Bensen JT.

Cancer Causes Control. 2016 Dec;27(12):1475-1485. Epub 2016 Nov 9.

10.

Predicting Prostate Cancer Recurrence After Radical Prostatectomy.

Jeffers A, Sochat V, Kattan MW, Yu C, Melcon E, Yamoah K, Rebbeck TR, Whittemore AS.

Prostate. 2017 Feb;77(3):291-298. doi: 10.1002/pros.23268. Epub 2016 Oct 24. Erratum in: Prostate. 2017 Jun;77(8):934.

11.

Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Vidal AC, Howard LE, Sun SX, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ.

Prostate Cancer Prostatic Dis. 2017 Mar;20(1):72-78. doi: 10.1038/pcan.2016.47. Epub 2016 Oct 4.

12.

Dietary energy restriction reduces high-fat diet-enhanced metastasis of Lewis lung carcinoma in mice.

Sundaram S, Yan L.

Oncotarget. 2016 Oct 4;7(40):65669-65675. doi: 10.18632/oncotarget.11598.

13.

The Relationship between Obesity, Prostate Tumor Infiltrating Lymphocytes and Macrophages, and Biochemical Failure.

Zeigler-Johnson C, Morales KH, Lal P, Feldman M.

PLoS One. 2016 Aug 3;11(8):e0159109. doi: 10.1371/journal.pone.0159109. eCollection 2016.

14.

The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer.

Yamoah K, Zeigler-Johnson CM, Jeffers A, Malkowicz B, Spangler E, Park JY, Whittemore A, Rebbeck TR.

BMC Cancer. 2016 Jul 29;16:557. doi: 10.1186/s12885-016-2572-y.

15.

Risk of Cardiovascular Disease Using Framingham Risk Score in Korean Cancer Survivors.

So JH, Lee JK, Shin JY, Park W.

Korean J Fam Med. 2016 Jul;37(4):235-41. doi: 10.4082/kjfm.2016.37.4.235. Epub 2016 Jul 21.

16.

Racial and Ethnic Differences in Health Behaviors and Preventive Health Services Among Prostate Cancer Survivors in the United States.

Li J, Thompson TD, Richards TB, Steele CB.

Prev Chronic Dis. 2016 Jul 21;13:E95. doi: 10.5888/pcd13.160148.

17.

Demography and disease characteristics of prostate cancer in India.

Hariharan K, Padmanabha V.

Indian J Urol. 2016 Apr-Jun;32(2):103-8. doi: 10.4103/0970-1591.174774. Review.

18.
19.

Fortifying the Treatment of Prostate Cancer with Physical Activity.

Champ CE, Francis L, Klement RJ, Dickerman R, Smith RP.

Prostate Cancer. 2016;2016:9462975. doi: 10.1155/2016/9462975. Epub 2016 Feb 10. Review.

20.

Impact of obesity on functional and oncological outcomes in radical perineal prostatectomy.

Altay B, Erkurt B, Guzelburc V, Kiremit MC, Boz MY, Albayrak S.

Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E766-9. doi: 10.5489/cuaj.3094. Epub 2015 Nov 4.

Supplemental Content

Support Center